nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2E1—type 2 diabetes mellitus	0.113	0.313	CbGaD
Etoricoxib—CYP1A2—type 2 diabetes mellitus	0.108	0.298	CbGaD
Etoricoxib—CYP3A4—type 2 diabetes mellitus	0.0713	0.197	CbGaD
Etoricoxib—PTGS2—type 2 diabetes mellitus	0.0698	0.193	CbGaD
Etoricoxib—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0186	0.0468	CbGbCtD
Etoricoxib—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0182	0.0457	CbGbCtD
Etoricoxib—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0166	0.0418	CbGbCtD
Etoricoxib—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0158	0.0398	CbGbCtD
Etoricoxib—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0158	0.0398	CbGbCtD
Etoricoxib—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0155	0.0389	CbGbCtD
Etoricoxib—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0146	0.0367	CbGbCtD
Etoricoxib—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0141	0.0354	CbGbCtD
Etoricoxib—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0135	0.0339	CbGbCtD
Etoricoxib—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0131	0.0331	CbGbCtD
Etoricoxib—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0131	0.0331	CbGbCtD
Etoricoxib—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0121	0.0305	CbGbCtD
Etoricoxib—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.012	0.0302	CbGbCtD
Etoricoxib—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0119	0.0298	CbGbCtD
Etoricoxib—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0117	0.0295	CbGbCtD
Etoricoxib—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0111	0.0279	CbGbCtD
Etoricoxib—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0107	0.0269	CbGbCtD
Etoricoxib—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0106	0.0267	CbGbCtD
Etoricoxib—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0106	0.0266	CbGbCtD
Etoricoxib—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.01	0.0252	CbGbCtD
Etoricoxib—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00996	0.0251	CbGbCtD
Etoricoxib—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00967	0.0243	CbGbCtD
Etoricoxib—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00955	0.024	CbGbCtD
Etoricoxib—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00911	0.0229	CbGbCtD
Etoricoxib—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00873	0.022	CbGbCtD
Etoricoxib—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00845	0.0213	CbGbCtD
Etoricoxib—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00809	0.0204	CbGbCtD
Etoricoxib—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00764	0.0192	CbGbCtD
Etoricoxib—CYP2C19—Losartan—type 2 diabetes mellitus	0.0074	0.0186	CbGbCtD
Etoricoxib—CYP1A2—Losartan—type 2 diabetes mellitus	0.00683	0.0172	CbGbCtD
Etoricoxib—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00673	0.0169	CbGbCtD
Etoricoxib—CYP2C9—Losartan—type 2 diabetes mellitus	0.00615	0.0155	CbGbCtD
Etoricoxib—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00579	0.0146	CbGbCtD
Etoricoxib—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00555	0.014	CbGbCtD
Etoricoxib—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00555	0.014	CbGbCtD
Etoricoxib—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00525	0.0132	CbGbCtD
Etoricoxib—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00391	0.00984	CbGbCtD
Etoricoxib—CYP3A4—Losartan—type 2 diabetes mellitus	0.00358	0.009	CbGbCtD
Etoricoxib—Vemurafenib—CYP1A2—type 2 diabetes mellitus	0.000687	0.252	CrCbGaD
Etoricoxib—PTGS2—leg—type 2 diabetes mellitus	0.000515	0.118	CbGeAlD
Etoricoxib—PTGS2—hindlimb—type 2 diabetes mellitus	0.00046	0.105	CbGeAlD
Etoricoxib—Vemurafenib—CYP3A4—type 2 diabetes mellitus	0.000454	0.167	CrCbGaD
Etoricoxib—Vemurafenib—ALB—type 2 diabetes mellitus	0.000396	0.145	CrCbGaD
Etoricoxib—MAPK14—cardiovascular system—type 2 diabetes mellitus	0.000341	0.0781	CbGeAlD
Etoricoxib—MAPK14—kidney—type 2 diabetes mellitus	0.000334	0.0764	CbGeAlD
Etoricoxib—MAPK14—adipose tissue—type 2 diabetes mellitus	0.000301	0.0689	CbGeAlD
Etoricoxib—PTGS2—artery—type 2 diabetes mellitus	0.000282	0.0646	CbGeAlD
Etoricoxib—Celecoxib—CYP3A4—type 2 diabetes mellitus	0.000267	0.0979	CrCbGaD
Etoricoxib—Celecoxib—PTGS2—type 2 diabetes mellitus	0.000261	0.0959	CrCbGaD
Etoricoxib—PTGS2—endothelium—type 2 diabetes mellitus	0.000238	0.0546	CbGeAlD
Etoricoxib—Celecoxib—ALB—type 2 diabetes mellitus	0.000233	0.0854	CrCbGaD
Etoricoxib—Vismodegib—CYP3A4—type 2 diabetes mellitus	0.000229	0.0839	CrCbGaD
Etoricoxib—MAPK14—liver—type 2 diabetes mellitus	0.000211	0.0483	CbGeAlD
Etoricoxib—Vismodegib—ALB—type 2 diabetes mellitus	0.0002	0.0732	CrCbGaD
Etoricoxib—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000136	0.031	CbGeAlD
Etoricoxib—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000119	0.0271	CbGeAlD
Etoricoxib—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000112	0.0257	CbGeAlD
Etoricoxib—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000106	0.0244	CbGeAlD
Etoricoxib—CYP2E1—kidney—type 2 diabetes mellitus	0.000104	0.0239	CbGeAlD
Etoricoxib—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000101	0.0232	CbGeAlD
Etoricoxib—PTGS2—cardiovascular system—type 2 diabetes mellitus	9.81e-05	0.0225	CbGeAlD
Etoricoxib—PTGS2—kidney—type 2 diabetes mellitus	9.59e-05	0.022	CbGeAlD
Etoricoxib—PTGS2—pancreas—type 2 diabetes mellitus	9.53e-05	0.0218	CbGeAlD
Etoricoxib—CYP2C19—liver—type 2 diabetes mellitus	8.96e-05	0.0205	CbGeAlD
Etoricoxib—PTGS2—adipose tissue—type 2 diabetes mellitus	8.65e-05	0.0198	CbGeAlD
Etoricoxib—CYP3A4—kidney—type 2 diabetes mellitus	8.38e-05	0.0192	CbGeAlD
Etoricoxib—CYP2D6—kidney—type 2 diabetes mellitus	8.25e-05	0.0189	CbGeAlD
Etoricoxib—CYP1A2—liver—type 2 diabetes mellitus	7.32e-05	0.0168	CbGeAlD
Etoricoxib—CYP2C9—liver—type 2 diabetes mellitus	6.95e-05	0.0159	CbGeAlD
Etoricoxib—CYP2E1—liver—type 2 diabetes mellitus	6.59e-05	0.0151	CbGeAlD
Etoricoxib—PTGS2—liver—type 2 diabetes mellitus	6.06e-05	0.0139	CbGeAlD
Etoricoxib—Visual impairment—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000393	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	5.98e-05	0.000392	CcSEcCtD
Etoricoxib—Fatigue—Gliclazide—type 2 diabetes mellitus	5.97e-05	0.000392	CcSEcCtD
Etoricoxib—Nausea—Glipizide—type 2 diabetes mellitus	5.95e-05	0.000391	CcSEcCtD
Etoricoxib—Vomiting—Glimepiride—type 2 diabetes mellitus	5.95e-05	0.00039	CcSEcCtD
Etoricoxib—Vision blurred—Losartan—type 2 diabetes mellitus	5.94e-05	0.00039	CcSEcCtD
Etoricoxib—Vomiting—Sitagliptin—type 2 diabetes mellitus	5.93e-05	0.000389	CcSEcCtD
Etoricoxib—Pain—Gliclazide—type 2 diabetes mellitus	5.92e-05	0.000389	CcSEcCtD
Etoricoxib—Constipation—Gliclazide—type 2 diabetes mellitus	5.92e-05	0.000389	CcSEcCtD
Etoricoxib—Tremor—Losartan—type 2 diabetes mellitus	5.91e-05	0.000388	CcSEcCtD
Etoricoxib—Rash—Glimepiride—type 2 diabetes mellitus	5.9e-05	0.000387	CcSEcCtD
Etoricoxib—Dermatitis—Glimepiride—type 2 diabetes mellitus	5.89e-05	0.000386	CcSEcCtD
Etoricoxib—Rash—Sitagliptin—type 2 diabetes mellitus	5.88e-05	0.000386	CcSEcCtD
Etoricoxib—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.87e-05	0.000385	CcSEcCtD
Etoricoxib—Erythema multiforme—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000385	CcSEcCtD
Etoricoxib—Headache—Glimepiride—type 2 diabetes mellitus	5.86e-05	0.000384	CcSEcCtD
Etoricoxib—Cough—Irbesartan—type 2 diabetes mellitus	5.85e-05	0.000384	CcSEcCtD
Etoricoxib—Headache—Sitagliptin—type 2 diabetes mellitus	5.84e-05	0.000383	CcSEcCtD
Etoricoxib—Anaemia—Losartan—type 2 diabetes mellitus	5.83e-05	0.000382	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.8e-05	0.00038	CcSEcCtD
Etoricoxib—Agitation—Losartan—type 2 diabetes mellitus	5.8e-05	0.00038	CcSEcCtD
Etoricoxib—Oedema—Metformin—type 2 diabetes mellitus	5.79e-05	0.00038	CcSEcCtD
Etoricoxib—Tinnitus—Ramipril—type 2 diabetes mellitus	5.79e-05	0.00038	CcSEcCtD
Etoricoxib—Hypertension—Irbesartan—type 2 diabetes mellitus	5.79e-05	0.000379	CcSEcCtD
Etoricoxib—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.77e-05	0.000379	CcSEcCtD
Etoricoxib—Flushing—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000378	CcSEcCtD
Etoricoxib—Angioedema—Losartan—type 2 diabetes mellitus	5.76e-05	0.000378	CcSEcCtD
Etoricoxib—Infection—Metformin—type 2 diabetes mellitus	5.76e-05	0.000378	CcSEcCtD
Etoricoxib—Insomnia—Valsartan—type 2 diabetes mellitus	5.76e-05	0.000378	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.73e-05	0.000376	CcSEcCtD
Etoricoxib—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.71e-05	0.000374	CcSEcCtD
Etoricoxib—Chest pain—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.000374	CcSEcCtD
Etoricoxib—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.000374	CcSEcCtD
Etoricoxib—Shock—Metformin—type 2 diabetes mellitus	5.7e-05	0.000374	CcSEcCtD
Etoricoxib—Insomnia—Orlistat—type 2 diabetes mellitus	5.69e-05	0.000373	CcSEcCtD
Etoricoxib—Anxiety—Irbesartan—type 2 diabetes mellitus	5.68e-05	0.000373	CcSEcCtD
Etoricoxib—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.68e-05	0.000373	CcSEcCtD
Etoricoxib—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.68e-05	0.000373	CcSEcCtD
Etoricoxib—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.67e-05	0.000372	CcSEcCtD
Etoricoxib—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.67e-05	0.000372	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000372	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.66e-05	0.000372	CcSEcCtD
Etoricoxib—Somnolence—Valsartan—type 2 diabetes mellitus	5.66e-05	0.000371	CcSEcCtD
Etoricoxib—Skin disorder—Metformin—type 2 diabetes mellitus	5.63e-05	0.000369	CcSEcCtD
Etoricoxib—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000368	CcSEcCtD
Etoricoxib—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.6e-05	0.000367	CcSEcCtD
Etoricoxib—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000367	CcSEcCtD
Etoricoxib—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.58e-05	0.000366	CcSEcCtD
Etoricoxib—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000366	CcSEcCtD
Etoricoxib—Palpitations—Losartan—type 2 diabetes mellitus	5.57e-05	0.000366	CcSEcCtD
Etoricoxib—Nausea—Glimepiride—type 2 diabetes mellitus	5.56e-05	0.000364	CcSEcCtD
Etoricoxib—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000364	CcSEcCtD
Etoricoxib—Nausea—Sitagliptin—type 2 diabetes mellitus	5.54e-05	0.000363	CcSEcCtD
Etoricoxib—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.54e-05	0.000363	CcSEcCtD
Etoricoxib—Asthenia—Glyburide—type 2 diabetes mellitus	5.53e-05	0.000363	CcSEcCtD
Etoricoxib—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.53e-05	0.000363	CcSEcCtD
Etoricoxib—Anorexia—Metformin—type 2 diabetes mellitus	5.52e-05	0.000362	CcSEcCtD
Etoricoxib—Cough—Losartan—type 2 diabetes mellitus	5.5e-05	0.000361	CcSEcCtD
Etoricoxib—Urticaria—Gliclazide—type 2 diabetes mellitus	5.5e-05	0.000361	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.49e-05	0.00036	CcSEcCtD
Etoricoxib—Alopecia—Ramipril—type 2 diabetes mellitus	5.49e-05	0.00036	CcSEcCtD
Etoricoxib—Fatigue—Valsartan—type 2 diabetes mellitus	5.49e-05	0.00036	CcSEcCtD
Etoricoxib—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.48e-05	0.000359	CcSEcCtD
Etoricoxib—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000359	CcSEcCtD
Etoricoxib—Oedema—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000359	CcSEcCtD
Etoricoxib—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.47e-05	0.000359	CcSEcCtD
Etoricoxib—Pruritus—Glyburide—type 2 diabetes mellitus	5.46e-05	0.000358	CcSEcCtD
Etoricoxib—Mental disorder—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000357	CcSEcCtD
Etoricoxib—Constipation—Valsartan—type 2 diabetes mellitus	5.44e-05	0.000357	CcSEcCtD
Etoricoxib—Infection—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000356	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.43e-05	0.000356	CcSEcCtD
Etoricoxib—Fatigue—Orlistat—type 2 diabetes mellitus	5.42e-05	0.000356	CcSEcCtD
Etoricoxib—Malnutrition—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000355	CcSEcCtD
Etoricoxib—Erythema—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000355	CcSEcCtD
Etoricoxib—Shock—Irbesartan—type 2 diabetes mellitus	5.38e-05	0.000353	CcSEcCtD
Etoricoxib—Pain—Orlistat—type 2 diabetes mellitus	5.38e-05	0.000353	CcSEcCtD
Etoricoxib—Chest pain—Losartan—type 2 diabetes mellitus	5.37e-05	0.000352	CcSEcCtD
Etoricoxib—Arthralgia—Losartan—type 2 diabetes mellitus	5.37e-05	0.000352	CcSEcCtD
Etoricoxib—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.36e-05	0.000352	CcSEcCtD
Etoricoxib—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000352	CcSEcCtD
Etoricoxib—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000351	CcSEcCtD
Etoricoxib—Anxiety—Losartan—type 2 diabetes mellitus	5.35e-05	0.000351	CcSEcCtD
Etoricoxib—Rash—Bromocriptine—type 2 diabetes mellitus	5.32e-05	0.000349	CcSEcCtD
Etoricoxib—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.32e-05	0.000349	CcSEcCtD
Etoricoxib—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.31e-05	0.000348	CcSEcCtD
Etoricoxib—CYP3A4—liver—type 2 diabetes mellitus	5.3e-05	0.0121	CbGeAlD
Etoricoxib—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000347	CcSEcCtD
Etoricoxib—Headache—Bromocriptine—type 2 diabetes mellitus	5.29e-05	0.000347	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.28e-05	0.000346	CcSEcCtD
Etoricoxib—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.28e-05	0.000346	CcSEcCtD
Etoricoxib—Dry mouth—Losartan—type 2 diabetes mellitus	5.25e-05	0.000344	CcSEcCtD
Etoricoxib—CYP2D6—liver—type 2 diabetes mellitus	5.21e-05	0.0119	CbGeAlD
Etoricoxib—Anorexia—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000342	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.2e-05	0.000341	CcSEcCtD
Etoricoxib—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000341	CcSEcCtD
Etoricoxib—Confusional state—Losartan—type 2 diabetes mellitus	5.19e-05	0.00034	CcSEcCtD
Etoricoxib—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.18e-05	0.00034	CcSEcCtD
Etoricoxib—Dyspnoea—Metformin—type 2 diabetes mellitus	5.17e-05	0.000339	CcSEcCtD
Etoricoxib—Somnolence—Metformin—type 2 diabetes mellitus	5.15e-05	0.000338	CcSEcCtD
Etoricoxib—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.15e-05	0.000338	CcSEcCtD
Etoricoxib—Oedema—Losartan—type 2 diabetes mellitus	5.15e-05	0.000338	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.14e-05	0.000337	CcSEcCtD
Etoricoxib—Infection—Losartan—type 2 diabetes mellitus	5.11e-05	0.000335	CcSEcCtD
Etoricoxib—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.1e-05	0.000335	CcSEcCtD
Etoricoxib—Dyspepsia—Metformin—type 2 diabetes mellitus	5.1e-05	0.000335	CcSEcCtD
Etoricoxib—Tremor—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000332	CcSEcCtD
Etoricoxib—Shock—Losartan—type 2 diabetes mellitus	5.06e-05	0.000332	CcSEcCtD
Etoricoxib—Urticaria—Valsartan—type 2 diabetes mellitus	5.06e-05	0.000332	CcSEcCtD
Etoricoxib—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.05e-05	0.000331	CcSEcCtD
Etoricoxib—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.04e-05	0.000331	CcSEcCtD
Etoricoxib—Decreased appetite—Metformin—type 2 diabetes mellitus	5.04e-05	0.00033	CcSEcCtD
Etoricoxib—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.03e-05	0.00033	CcSEcCtD
Etoricoxib—Nausea—Bromocriptine—type 2 diabetes mellitus	5.01e-05	0.000329	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5e-05	0.000328	CcSEcCtD
Etoricoxib—Fatigue—Metformin—type 2 diabetes mellitus	5e-05	0.000328	CcSEcCtD
Etoricoxib—Urticaria—Orlistat—type 2 diabetes mellitus	5e-05	0.000328	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000327	CcSEcCtD
Etoricoxib—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.97e-05	0.000326	CcSEcCtD
Etoricoxib—Asthenia—Gliclazide—type 2 diabetes mellitus	4.97e-05	0.000326	CcSEcCtD
Etoricoxib—Agitation—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000326	CcSEcCtD
Etoricoxib—Constipation—Metformin—type 2 diabetes mellitus	4.96e-05	0.000325	CcSEcCtD
Etoricoxib—Angioedema—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000324	CcSEcCtD
Etoricoxib—Anorexia—Losartan—type 2 diabetes mellitus	4.91e-05	0.000322	CcSEcCtD
Etoricoxib—Vomiting—Glyburide—type 2 diabetes mellitus	4.9e-05	0.000322	CcSEcCtD
Etoricoxib—Pruritus—Gliclazide—type 2 diabetes mellitus	4.9e-05	0.000321	CcSEcCtD
Etoricoxib—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.88e-05	0.00032	CcSEcCtD
Etoricoxib—Rash—Glyburide—type 2 diabetes mellitus	4.86e-05	0.000319	CcSEcCtD
Etoricoxib—Somnolence—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000319	CcSEcCtD
Etoricoxib—Dermatitis—Glyburide—type 2 diabetes mellitus	4.86e-05	0.000319	CcSEcCtD
Etoricoxib—Headache—Glyburide—type 2 diabetes mellitus	4.83e-05	0.000317	CcSEcCtD
Etoricoxib—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.81e-05	0.000316	CcSEcCtD
Etoricoxib—Palpitations—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000313	CcSEcCtD
Etoricoxib—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.78e-05	0.000313	CcSEcCtD
Etoricoxib—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.75e-05	0.000312	CcSEcCtD
Etoricoxib—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.74e-05	0.000311	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.74e-05	0.000311	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.00031	CcSEcCtD
Etoricoxib—Cough—Ramipril—type 2 diabetes mellitus	4.72e-05	0.00031	CcSEcCtD
Etoricoxib—Fatigue—Irbesartan—type 2 diabetes mellitus	4.71e-05	0.000309	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.69e-05	0.000308	CcSEcCtD
Etoricoxib—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.69e-05	0.000308	CcSEcCtD
Etoricoxib—Pain—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000307	CcSEcCtD
Etoricoxib—Constipation—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000307	CcSEcCtD
Etoricoxib—Insomnia—Losartan—type 2 diabetes mellitus	4.65e-05	0.000305	CcSEcCtD
Etoricoxib—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.63e-05	0.000304	CcSEcCtD
Etoricoxib—Urticaria—Metformin—type 2 diabetes mellitus	4.6e-05	0.000302	CcSEcCtD
Etoricoxib—Arthralgia—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000302	CcSEcCtD
Etoricoxib—Chest pain—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000302	CcSEcCtD
Etoricoxib—Dyspnoea—Losartan—type 2 diabetes mellitus	4.59e-05	0.000301	CcSEcCtD
Etoricoxib—Anxiety—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000301	CcSEcCtD
Etoricoxib—Nausea—Glyburide—type 2 diabetes mellitus	4.58e-05	0.000301	CcSEcCtD
Etoricoxib—Abdominal pain—Metformin—type 2 diabetes mellitus	4.58e-05	0.0003	CcSEcCtD
Etoricoxib—Dizziness—Gliclazide—type 2 diabetes mellitus	4.58e-05	0.0003	CcSEcCtD
Etoricoxib—Somnolence—Losartan—type 2 diabetes mellitus	4.58e-05	0.0003	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.57e-05	0.0003	CcSEcCtD
Etoricoxib—Asthenia—Valsartan—type 2 diabetes mellitus	4.57e-05	0.000299	CcSEcCtD
Etoricoxib—Dyspepsia—Losartan—type 2 diabetes mellitus	4.53e-05	0.000297	CcSEcCtD
Etoricoxib—Asthenia—Orlistat—type 2 diabetes mellitus	4.51e-05	0.000296	CcSEcCtD
Etoricoxib—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000296	CcSEcCtD
Etoricoxib—Pruritus—Valsartan—type 2 diabetes mellitus	4.5e-05	0.000295	CcSEcCtD
Etoricoxib—Dry mouth—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000295	CcSEcCtD
Etoricoxib—Decreased appetite—Losartan—type 2 diabetes mellitus	4.47e-05	0.000293	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.47e-05	0.000293	CcSEcCtD
Etoricoxib—Confusional state—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000292	CcSEcCtD
Etoricoxib—Pruritus—Orlistat—type 2 diabetes mellitus	4.45e-05	0.000292	CcSEcCtD
Etoricoxib—Fatigue—Losartan—type 2 diabetes mellitus	4.44e-05	0.000291	CcSEcCtD
Etoricoxib—Oedema—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000289	CcSEcCtD
Etoricoxib—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000289	CcSEcCtD
Etoricoxib—Vomiting—Gliclazide—type 2 diabetes mellitus	4.4e-05	0.000289	CcSEcCtD
Etoricoxib—Constipation—Losartan—type 2 diabetes mellitus	4.4e-05	0.000289	CcSEcCtD
Etoricoxib—Pain—Losartan—type 2 diabetes mellitus	4.4e-05	0.000289	CcSEcCtD
Etoricoxib—Rash—Gliclazide—type 2 diabetes mellitus	4.37e-05	0.000286	CcSEcCtD
Etoricoxib—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.36e-05	0.000286	CcSEcCtD
Etoricoxib—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.35e-05	0.000286	CcSEcCtD
Etoricoxib—Urticaria—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.000285	CcSEcCtD
Etoricoxib—Shock—Ramipril—type 2 diabetes mellitus	4.34e-05	0.000285	CcSEcCtD
Etoricoxib—Headache—Gliclazide—type 2 diabetes mellitus	4.34e-05	0.000285	CcSEcCtD
Etoricoxib—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000284	CcSEcCtD
Etoricoxib—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000284	CcSEcCtD
Etoricoxib—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000283	CcSEcCtD
Etoricoxib—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.3e-05	0.000282	CcSEcCtD
Etoricoxib—Skin disorder—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000281	CcSEcCtD
Etoricoxib—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.24e-05	0.000278	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.21e-05	0.000276	CcSEcCtD
Etoricoxib—Dizziness—Valsartan—type 2 diabetes mellitus	4.21e-05	0.000276	CcSEcCtD
Etoricoxib—Anorexia—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000276	CcSEcCtD
Etoricoxib—Dizziness—Orlistat—type 2 diabetes mellitus	4.16e-05	0.000273	CcSEcCtD
Etoricoxib—Asthenia—Metformin—type 2 diabetes mellitus	4.16e-05	0.000273	CcSEcCtD
Etoricoxib—Nausea—Gliclazide—type 2 diabetes mellitus	4.11e-05	0.00027	CcSEcCtD
Etoricoxib—Pruritus—Metformin—type 2 diabetes mellitus	4.1e-05	0.000269	CcSEcCtD
Etoricoxib—Urticaria—Losartan—type 2 diabetes mellitus	4.09e-05	0.000268	CcSEcCtD
Etoricoxib—Abdominal pain—Losartan—type 2 diabetes mellitus	4.07e-05	0.000267	CcSEcCtD
Etoricoxib—Vomiting—Valsartan—type 2 diabetes mellitus	4.05e-05	0.000265	CcSEcCtD
Etoricoxib—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.000264	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000264	CcSEcCtD
Etoricoxib—Rash—Valsartan—type 2 diabetes mellitus	4.01e-05	0.000263	CcSEcCtD
Etoricoxib—Dermatitis—Valsartan—type 2 diabetes mellitus	4.01e-05	0.000263	CcSEcCtD
Etoricoxib—Vomiting—Orlistat—type 2 diabetes mellitus	4e-05	0.000262	CcSEcCtD
Etoricoxib—Insomnia—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000262	CcSEcCtD
Etoricoxib—Headache—Valsartan—type 2 diabetes mellitus	3.99e-05	0.000262	CcSEcCtD
Etoricoxib—Diarrhoea—Metformin—type 2 diabetes mellitus	3.96e-05	0.00026	CcSEcCtD
Etoricoxib—Rash—Orlistat—type 2 diabetes mellitus	3.96e-05	0.00026	CcSEcCtD
Etoricoxib—Dermatitis—Orlistat—type 2 diabetes mellitus	3.96e-05	0.00026	CcSEcCtD
Etoricoxib—Headache—Orlistat—type 2 diabetes mellitus	3.94e-05	0.000258	CcSEcCtD
Etoricoxib—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000258	CcSEcCtD
Etoricoxib—Asthenia—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000257	CcSEcCtD
Etoricoxib—Somnolence—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000257	CcSEcCtD
Etoricoxib—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000255	CcSEcCtD
Etoricoxib—Pruritus—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.000254	CcSEcCtD
Etoricoxib—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000252	CcSEcCtD
Etoricoxib—Dizziness—Metformin—type 2 diabetes mellitus	3.83e-05	0.000251	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.81e-05	0.00025	CcSEcCtD
Etoricoxib—Fatigue—Ramipril—type 2 diabetes mellitus	3.8e-05	0.00025	CcSEcCtD
Etoricoxib—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.79e-05	0.000249	CcSEcCtD
Etoricoxib—Nausea—Valsartan—type 2 diabetes mellitus	3.78e-05	0.000248	CcSEcCtD
Etoricoxib—Constipation—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000248	CcSEcCtD
Etoricoxib—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.000245	CcSEcCtD
Etoricoxib—Nausea—Orlistat—type 2 diabetes mellitus	3.73e-05	0.000245	CcSEcCtD
Etoricoxib—Asthenia—Losartan—type 2 diabetes mellitus	3.69e-05	0.000242	CcSEcCtD
Etoricoxib—Vomiting—Metformin—type 2 diabetes mellitus	3.68e-05	0.000242	CcSEcCtD
Etoricoxib—Rash—Metformin—type 2 diabetes mellitus	3.65e-05	0.00024	CcSEcCtD
Etoricoxib—Dermatitis—Metformin—type 2 diabetes mellitus	3.65e-05	0.000239	CcSEcCtD
Etoricoxib—Pruritus—Losartan—type 2 diabetes mellitus	3.64e-05	0.000239	CcSEcCtD
Etoricoxib—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000239	CcSEcCtD
Etoricoxib—Headache—Metformin—type 2 diabetes mellitus	3.63e-05	0.000238	CcSEcCtD
Etoricoxib—Dizziness—Irbesartan—type 2 diabetes mellitus	3.62e-05	0.000237	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000237	CcSEcCtD
Etoricoxib—Diarrhoea—Losartan—type 2 diabetes mellitus	3.52e-05	0.000231	CcSEcCtD
Etoricoxib—Urticaria—Ramipril—type 2 diabetes mellitus	3.51e-05	0.00023	CcSEcCtD
Etoricoxib—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000229	CcSEcCtD
Etoricoxib—Vomiting—Irbesartan—type 2 diabetes mellitus	3.48e-05	0.000228	CcSEcCtD
Etoricoxib—Rash—Irbesartan—type 2 diabetes mellitus	3.45e-05	0.000226	CcSEcCtD
Etoricoxib—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.44e-05	0.000226	CcSEcCtD
Etoricoxib—Nausea—Metformin—type 2 diabetes mellitus	3.44e-05	0.000226	CcSEcCtD
Etoricoxib—Headache—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000225	CcSEcCtD
Etoricoxib—Dizziness—Losartan—type 2 diabetes mellitus	3.4e-05	0.000223	CcSEcCtD
Etoricoxib—Vomiting—Losartan—type 2 diabetes mellitus	3.27e-05	0.000215	CcSEcCtD
Etoricoxib—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000213	CcSEcCtD
Etoricoxib—Nausea—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000213	CcSEcCtD
Etoricoxib—Rash—Losartan—type 2 diabetes mellitus	3.25e-05	0.000213	CcSEcCtD
Etoricoxib—Dermatitis—Losartan—type 2 diabetes mellitus	3.24e-05	0.000213	CcSEcCtD
Etoricoxib—Headache—Losartan—type 2 diabetes mellitus	3.22e-05	0.000211	CcSEcCtD
Etoricoxib—Asthenia—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000208	CcSEcCtD
Etoricoxib—Pruritus—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000205	CcSEcCtD
Etoricoxib—Nausea—Losartan—type 2 diabetes mellitus	3.06e-05	0.000201	CcSEcCtD
Etoricoxib—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000198	CcSEcCtD
Etoricoxib—Dizziness—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000191	CcSEcCtD
Etoricoxib—Vomiting—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000184	CcSEcCtD
Etoricoxib—Rash—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000183	CcSEcCtD
Etoricoxib—Dermatitis—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000182	CcSEcCtD
Etoricoxib—Headache—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000181	CcSEcCtD
Etoricoxib—Nausea—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000172	CcSEcCtD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.78e-06	4.65e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.77e-06	4.64e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.76e-06	4.64e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	3.76e-06	4.64e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.76e-06	4.64e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS2—type 2 diabetes mellitus	3.76e-06	4.63e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.74e-06	4.61e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.74e-06	4.61e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.74e-06	4.61e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.74e-06	4.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.73e-06	4.6e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.73e-06	4.6e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.73e-06	4.6e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.72e-06	4.58e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.71e-06	4.58e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	3.71e-06	4.58e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	3.7e-06	4.56e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.65e-06	4.51e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.65e-06	4.5e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.65e-06	4.5e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.63e-06	4.48e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.63e-06	4.48e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.63e-06	4.48e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.63e-06	4.48e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	3.63e-06	4.47e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.62e-06	4.46e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.61e-06	4.45e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	3.61e-06	4.44e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IRS1—type 2 diabetes mellitus	3.6e-06	4.44e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.59e-06	4.42e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.58e-06	4.41e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.58e-06	4.41e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	3.56e-06	4.39e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.56e-06	4.39e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.55e-06	4.37e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.55e-06	4.37e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.49e-06	4.3e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.48e-06	4.29e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.47e-06	4.28e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.46e-06	4.27e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	3.45e-06	4.25e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—INS—type 2 diabetes mellitus	3.45e-06	4.25e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.44e-06	4.24e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.43e-06	4.23e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.43e-06	4.23e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.42e-06	4.21e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.4e-06	4.19e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.4e-06	4.19e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	3.39e-06	4.18e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	3.38e-06	4.17e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.36e-06	4.15e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.35e-06	4.13e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.35e-06	4.13e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.35e-06	4.13e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.35e-06	4.13e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	3.34e-06	4.12e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT2—type 2 diabetes mellitus	3.33e-06	4.11e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—type 2 diabetes mellitus	3.32e-06	4.1e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.31e-06	4.08e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.31e-06	4.08e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.29e-06	4.06e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.26e-06	4.02e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.25e-06	4e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.24e-06	3.99e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.22e-06	3.97e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.22e-06	3.96e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.22e-06	3.96e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.2e-06	3.95e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.19e-06	3.94e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.19e-06	3.93e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.18e-06	3.92e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	3.17e-06	3.9e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.16e-06	3.89e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.14e-06	3.88e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RELA—type 2 diabetes mellitus	3.12e-06	3.84e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.07e-06	3.78e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.07e-06	3.78e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.03e-06	3.74e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS3—type 2 diabetes mellitus	3.02e-06	3.73e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	3.02e-06	3.73e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.02e-06	3.73e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.98e-06	3.68e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.96e-06	3.65e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.96e-06	3.65e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.96e-06	3.65e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.96e-06	3.65e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.96e-06	3.65e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.94e-06	3.63e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	2.94e-06	3.63e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.94e-06	3.63e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.93e-06	3.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.93e-06	3.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.93e-06	3.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.92e-06	3.6e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.91e-06	3.58e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.91e-06	3.58e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.9e-06	3.58e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.9e-06	3.58e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—INS—type 2 diabetes mellitus	2.89e-06	3.56e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.88e-06	3.56e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.88e-06	3.56e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.88e-06	3.56e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.88e-06	3.55e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.87e-06	3.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.87e-06	3.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.86e-06	3.52e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.82e-06	3.48e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.82e-06	3.47e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.81e-06	3.47e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.8e-06	3.45e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.78e-06	3.43e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.78e-06	3.43e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.77e-06	3.42e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.75e-06	3.39e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.74e-06	3.38e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.72e-06	3.35e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.72e-06	3.35e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.69e-06	3.32e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.67e-06	3.29e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.66e-06	3.28e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	2.65e-06	3.26e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.64e-06	3.25e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.64e-06	3.25e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.63e-06	3.24e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.63e-06	3.24e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.61e-06	3.22e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.6e-06	3.21e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.59e-06	3.19e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.59e-06	3.19e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.59e-06	3.19e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.59e-06	3.19e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.56e-06	3.15e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—type 2 diabetes mellitus	2.55e-06	3.15e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.54e-06	3.13e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.54e-06	3.13e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.53e-06	3.12e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	2.53e-06	3.12e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.53e-06	3.11e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.52e-06	3.1e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.51e-06	3.09e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.51e-06	3.09e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.5e-06	3.09e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.5e-06	3.09e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.49e-06	3.07e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.49e-06	3.07e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.46e-06	3.04e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.46e-06	3.04e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.46e-06	3.03e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.45e-06	3.03e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SRC—type 2 diabetes mellitus	2.45e-06	3.02e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.43e-06	2.99e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.42e-06	2.99e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.4e-06	2.96e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.39e-06	2.95e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.39e-06	2.94e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.38e-06	2.94e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.38e-06	2.94e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.38e-06	2.93e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.37e-06	2.92e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.36e-06	2.91e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AKT1—type 2 diabetes mellitus	2.36e-06	2.9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—AKT1—type 2 diabetes mellitus	2.34e-06	2.89e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.34e-06	2.88e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.34e-06	2.88e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.32e-06	2.87e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.3e-06	2.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.28e-06	2.82e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.28e-06	2.81e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.26e-06	2.79e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.26e-06	2.78e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.25e-06	2.77e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.24e-06	2.77e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.24e-06	2.77e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.24e-06	2.76e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SRC—type 2 diabetes mellitus	2.24e-06	2.76e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.23e-06	2.75e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.23e-06	2.75e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.23e-06	2.74e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.21e-06	2.73e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.19e-06	2.7e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.18e-06	2.69e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.17e-06	2.67e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.15e-06	2.65e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.14e-06	2.64e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.14e-06	2.64e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.1e-06	2.58e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.05e-06	2.53e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.01e-06	2.48e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	2e-06	2.46e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.97e-06	2.42e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—type 2 diabetes mellitus	1.96e-06	2.42e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.95e-06	2.41e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.95e-06	2.4e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.93e-06	2.38e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.93e-06	2.38e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.93e-06	2.38e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.92e-06	2.37e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.92e-06	2.37e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.92e-06	2.37e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.91e-06	2.36e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.91e-06	2.36e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.9e-06	2.34e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.89e-06	2.33e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.84e-06	2.27e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-06	2.27e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-06	2.27e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.79e-06	2.21e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.77e-06	2.18e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.76e-06	2.17e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.75e-06	2.16e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.72e-06	2.12e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.72e-06	2.12e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.69e-06	2.08e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.69e-06	2.08e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-06	2.07e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.68e-06	2.07e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.68e-06	2.07e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.67e-06	2.06e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.67e-06	2.05e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.65e-06	2.04e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—type 2 diabetes mellitus	1.65e-06	2.04e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.63e-06	2.01e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.58e-06	1.95e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.55e-06	1.92e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	1.91e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.53e-06	1.89e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.52e-06	1.88e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.5e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.48e-06	1.83e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.48e-06	1.82e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.46e-06	1.8e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.43e-06	1.77e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.43e-06	1.77e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT1—type 2 diabetes mellitus	1.39e-06	1.71e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.31e-06	1.62e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.29e-06	1.58e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.26e-06	1.55e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.43e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.16e-06	1.42e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.11e-06	1.36e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.11e-06	1.36e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	1.35e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.01e-06	1.25e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.45e-07	1.04e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.77e-07	9.58e-06	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.71e-07	9.5e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.58e-07	8.12e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.08e-07	6.27e-06	CbGpPWpGaD
